Waitlist Only — Assessment Not Yet Open

Testosterone optimization is currently waitlist-only pending state-by-state controlled-substance workflow validation.

Pending Verification Endocrine Optimization

Endocrine Optimization Protocol

Testosterone optimization requires rigorous controlled-substance infrastructure. We are establishing validated clinical workflows state by state. Join the priority waitlist to be notified when intake opens in your state.

Join Priority Waitlist

Get Notified When TRT Opens

Enter your email below. You'll be among the first notified when testosterone intake routing is available in your state.

By submitting this form, you consent to ForgeVita collecting your email to notify you when routing opens. We do not sell or share your personal information. See our Privacy Policy for details.

About Testosterone Optimization

Understanding Hypogonadism & TRT

Clinical context for patients researching testosterone replacement therapy.

Testosterone is the primary male anabolic hormone responsible for muscle mass, bone density, libido, mood regulation, cognitive function, and energy levels. Production peaks in early adulthood and declines gradually with age — typically at a rate of roughly 1–2% per year after age 30.

Hypogonadism — clinically low testosterone — affects a significant portion of adult men, with prevalence increasing markedly with age. Symptoms can include persistent fatigue, reduced libido, difficulty building or maintaining muscle mass, increased body fat, mood disturbances including depression, cognitive fog, reduced bone density, and sleep disruption.

Importantly, diagnosis requires laboratory evaluation. Symptoms alone are insufficient to diagnose hypogonadism — serum testosterone levels (typically total and free testosterone) must be measured on at least two separate occasions in the morning, when levels are highest. Additional labs evaluating LH, FSH, prolactin, and thyroid function are commonly obtained to determine the etiology and guide treatment decisions.

Testosterone replacement therapy (TRT) carries meaningful risks and requires careful patient selection. It is not appropriate for men desiring to preserve fertility in the near term, as exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis and can significantly reduce or eliminate sperm production. All prescribing decisions will be made by independent licensed providers following full evaluation.

Why More Infrastructure Is Required

Controlled-Substance Compliance

Testosterone is not like other telehealth medications. Here's why it requires a separate, validated infrastructure before we can open intake.

DEA Schedule III

Schedule III Controlled Substance

Testosterone is classified as a DEA Schedule III controlled substance. Prescribing, dispensing, and telehealth delivery require strict adherence to federal and state controlled-substance regulations.

Required Baseline

Lab Coordination Required

Baseline and follow-up laboratory testing are typically required and may include morning testosterone levels, CBC, metabolic testing, PSA where clinically indicated, and other endocrine labs determined by the treating provider. Lab coordination infrastructure must be validated per state.

State-by-State

State-by-State Validation

Controlled-substance telemedicine rules vary significantly by state. Ryan Haight Act requirements, state-specific DEA rules, and prescribing authority boundaries must each be validated before intake is opened.

Identity & Compliance

Identity Verification

Schedule III prescribing workflows require identity verification as part of the regulatory prescribing infrastructure. This adds complexity that does not exist for non-controlled telehealth medications.

What TRT Will Look Like

The Full Intake Process

When TRT intake opens, here is what the process will involve. TRT generally requires a higher-touch clinical workflow than non-controlled telehealth programs.

01

Health Assessment & Lab Work

Complete a comprehensive health intake and arrange lab work through the coordinated lab partner. Baseline serum testosterone and supporting labs are required before evaluation proceeds.

02

Provider Review & Video Evaluation

An independent licensed provider reviews your lab results and health history. TRT may require synchronous video evaluation, identity verification, lab review, and in-person follow-up depending on federal law, state law, partner workflow, and provider judgment.

03

Identity Verification

Identity verification is a required component of the controlled-substance prescribing workflow. This step is completed prior to or concurrent with the prescription being issued.

04

Prescription & Ongoing Monitoring

If prescribed, medication is dispensed through a licensed pharmacy partner. Ongoing lab monitoring and follow-up provider evaluations are required components of continued treatment.

Common Questions

Frequently Asked Questions

What you need to know about the TRT waitlist and what to expect when it opens.

Why is this waitlist-only?
Testosterone is a DEA Schedule III controlled substance. Telehealth prescribing of controlled substances is subject to federal requirements under the Ryan Haight Online Pharmacy Consumer Protection Act, as well as state-specific controlled-substance telemedicine rules that vary significantly by jurisdiction. Each state must be individually validated before intake can open. We are not accepting assessments until that infrastructure is in place.
When will it open?
There is no fixed launch date. Controlled-substance compliance validation is not on a fixed timeline — it depends on regulatory developments, state-level rule clarification, and provider infrastructure readiness. Join the waitlist and you will be notified when intake opens in your state.
What forms of testosterone will be available?
The specific formulation is determined by the independent licensed provider at the time of evaluation based on your clinical profile, preferences, and state-level dispensing availability. Common forms include injectable testosterone cypionate, topical gels, and select oral preparations. The provider has full discretion over prescribing decisions.
Will labs be included?
Yes — lab evaluation is required before treatment and for ongoing monitoring during treatment. Lab coordination will be part of the intake workflow. Details on lab partner options, costs, and at-home vs. in-person draw options will be disclosed in the clinical partner workflow when intake opens.
Is insurance required?
No. ForgeVita operates outside traditional health insurance networks. All charges — including evaluation fees, lab costs, and medication — will be disclosed in full within the secure clinical partner workflow before you authorize any purchase. You pay directly.
Endocrine Optimization — Waitlist

Join the Priority Waitlist

Be among the first notified when testosterone intake routing opens in your state. No payment, no commitment.

Medical & Safety Disclosure: Testosterone replacement therapy requires laboratory evaluation and identity verification as part of the prescribing workflow. In some states or clinical circumstances, video evaluation or in-person assessment may be required. TRT carries significant risks including polycythemia (elevated red blood cell mass), cardiovascular effects, sleep apnea exacerbation, testicular atrophy, suppression of endogenous testosterone production, and substantially reduced or eliminated sperm production. TRT is contraindicated in patients with a current or historical diagnosis of prostate cancer or breast cancer. It is not appropriate for men wishing to preserve or restore fertility without additional medical management. This program is not currently open for intake. ForgeVita LLC is a technology and management services company and does not practice medicine, provide clinical services, or guarantee any treatment outcome. Treatment is never guaranteed. All prescribing decisions will be made by independent licensed providers at their sole clinical discretion.